Latest News - Cardinal Health
Top Corporates Hub
Cardinal Health
1 Large-Cap Stock to Consider Right Now and 2 That Underwhelm
10.04.2026 16:06
Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth rates as they’ve already captured significant portions of their markets.
Expanded Actinium‑225 Capacity And Higher EPS Guidance Could Be A Game Changer For Cardinal Health (CAH)
10.04.2026 09:18
In early April 2026, Cardinal Health announced a major expansion of Actinium-225 production at its Center for Theranostics Advancement in Indianapolis, adding a high-capacity line to its Drug Master File to boost cGMP-compliant supply for investigational and future commercial targeted alpha therapies worldwide. This expansion, which has already supported more than 15 clinical trials and growing global demand, underscores Cardinal Health’s emerging role as a key enabler of next-generation...
We Ran A Stock Scan For Earnings Growth And Cardinal Health (NYSE:CAH) Passed With Ease
09.04.2026 13:00
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
Cardinal Health Deepens Actinium-225 Role As Board Leadership Shifts
02.04.2026 00:18
Cardinal Health (NYSE:CAH) is expanding production capacity for the medical radioisotope Actinium-225 to support targeted alpha therapies for cancer treatment worldwide. The company is positioning this capacity for both clinical trials and potential commercial manufacturing in global markets. Cardinal Health announced that Patricia A. Hemingway Hall has been appointed Chair of the Board, following a period of company transformation. The leadership change and Actinium-225 expansion were...
Baxter International Unveils IV Verify to Enhance IV Labeling Accuracy
31.03.2026 12:41
BAX introduces the IV Verify system to improve IV labeling accuracy, targeting medication safety gaps and boosting workflow efficiency in clinical settings.
Reasons to Add Cooper Companies Stock to Your Portfolio Now
27.03.2026 12:51
COO rides on premium lens momentum and margin gains, but Asia weakness and geopolitical risks test near-term growth outlook.
2 Cash-Producing Stocks with Competitive Advantages and 1 We Brush Off
26.03.2026 07:25
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
Cardinal Health (CAH) Appoints New Chair as Gregory Kenny Steps Down
26.03.2026 05:21
Cardinal Health, Inc. (NYSE:CAH) is included among the Dividend Kings and Aristocrats List: 32 Biggest Stocks. On March 23, Cardinal Health, Inc. (NYSE:CAH) named Patricia A. Hemingway Hall as Chair of the Board, replacing Gregory B. Kenny following his retirement. The change is effective immediately. Kenny had been with the Board since 2007 and took […]
LivaNova Expands OSA Care With FDA-Approved aura6000 System
25.03.2026 15:18
LIVN wins FDA nod for its aura6000 sleep apnea system, marking a pivotal step in neurostimulation with strong trial results and new growth potential.
Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now
25.03.2026 15:13
FMS eyes growth on value-based care surge and FME25+ savings, but regulatory headwinds, flat volumes and China weakness cloud outlook.
3 Dividend Aristocrat Stocks Up 200% That Nobody Is Talking About
25.03.2026 14:54
Three top-performing Dividend Aristocrats delivered big 5-year gains, steady dividend growth, and still look positioned for more upside ahead.
Reasons to Retain TransMedics Stock in Your Portfolio for Now
25.03.2026 14:35
TMDX rides OCS adoption and strong fourth-quarter results, but margin pressure raises questions for investors.
MDT Expands Agreement With Merit to Offer ViaVerte: Stock to Gain?
25.03.2026 13:43
Medtronic expands its pain portfolio with a new ViaVerte BVNA system deal with Merit, aiming to tap rising demand for minimally invasive chronic pain treatments.
Is Astellas Pharma (ALPMY) Outperforming Other Medical Stocks This Year?
25.03.2026 13:40
Here is how Astellas Pharma Inc. (ALPMY) and Cardinal Health (CAH) have performed compared to their sector so far this year.
Cardinal Health (CAH) Emerged as a Key Contributor on Pharmaceutical Strength and Margin Expansion
25.03.2026 11:42
Renaissance Investment Management, an investment management company, released its Q4 2025 “Large Cap Growth Strategy” investor letter. A copy of the letter can be downloaded here. The strategy faced a difficult fourth quarter of 2025, underperforming both the S&P 500, which gained 2.7%, and the Russell 1000 Growth Index as market leadership remained concentrated in […]
Embecta to Acquire Owen Mumford to Expand Drug-Delivery Portfolio
23.03.2026 16:18
EMBC to acquire Owen Mumford for up to $199.4M, aiming to expand beyond diabetes into high-value drug delivery and boost long-term growth.
Are GLP-1 Drugs Becoming a Meaningful Revenue Driver for CAH Stock?
23.03.2026 15:26
CAH sees GLP-1 drugs boost revenue growth, but margins lag as strong demand lifts volumes without significantly improving profitability.
ECL to Boost Data Center AI Cooling Platform With CoolIT Acquisition
23.03.2026 14:27
Ecolab's $4.75B CoolIT deal boosts its AI data center cooling push, expanding into high-growth liquid cooling and unlocking recurring revenue opportunities.
Wall Street Analysts Think Cardinal (CAH) Is a Good Investment: Is It?
23.03.2026 13:30
The average brokerage recommendation (ABR) for Cardinal (CAH) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Cardinal Health Appoints Patricia A. Hemingway Hall as Board Chair
23.03.2026 10:45
Cardinal Health (NYSE: CAH) today announced that its Board of Directors has appointed Patricia A. Hemingway Hall to succeed Gregory B. Kenny as Chair of the Board following Mr. Kenny's retirement, effective immediately.